Goal setting in older adults with diabetes

Geriatric Diabetes

Volumn , Issue , 2007, Pages 271-281

  Huang, Elbert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48449091035     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Nathan DM, Singer DE, Godine JE, Perlmuter LC. Non-insulin-dependent diabetes in older patients: complications and risk factors. Am J Med 1986; 81: 837-842.
2. Nathan DM, Meigs JB, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is…or is it? Lancet 1997; 350(suppl 1): S14-S19.
3. Kuller LH. Stroke and diabetes. In: Harris MI, ed. Diabetes in America. 2nd ed. Bethesda: National Institutes of Health, 1995: 449-456.
4. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice 1995; 28: 103-117.
5. U.K. Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-853.
6. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Eng’l J Med 2003; 348(5): 383-393.
7. U.K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713.
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
9. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE System of Intensive Diabetes Self-Management-2002 Update. Endocr Pract 2002; 9(suppl 1): 41-82.
10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004; 27(suppl 1): S15-S35.
11. Brown AF, Mangione CM, Saliba D, Sarkisian CA, California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51(suppl 5 Guidelines): S265-S280.
12. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997; 20(suppl 1): S5-S13.
13. Joint National Committee on Prevention D, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157(21): 2413-2446.
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560-2572.
15. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999; 22(suppl 1): S32-S41.
16. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-239.
17. Bradley EH, Bogardus ST Jr, Tinetti ME, Inouye SK. Goal-setting in clinical medicine. Soc Sci Med 1999; 49(2): 267-278.
18. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980; 303: 130-135.
19. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005; 53: 306-311.
20. The Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353(25): 2643-2653.
21. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-412.
22. Huang ES, Meigs JB, Singer DE. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 2001; 111: 633-642.
23. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003; 138: 593-602.
24. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003; 348(1): 42-49.
25. Murray MD, Kroenke K. Polypharmacy and medical adherence. J Gen Intern Med 2001; 16: 137-139.
26. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24(6): 1069-1078.
27. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112.
28. Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 1996; 87(5 Pt 1): 715-721.
29. Greene DA, Stevens MJ, Feldman EL. Diabetic neuropathy: scope of the syndrome. Am J Med 1999; 107(2B): 2S-8S.
30. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group [published erratum appears in J Am Med Assoc 1997; 277(17): 1356] [see comments]. JAMA 1996; 276(23): 1886-1892.
31. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 1999; 355: 253-259.
32. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127(9): 788-795.
33. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997; 20(5): 735-744.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.
35. Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc 2003; 51: 451-458.
36. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295(7): 801-808.
37. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157(15): 1681-1686.
38. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281(21): 2005-2012.
39. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146-M156.
40. Saliba D, Elliott M, Rubenstein LV, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001; 49: 1691-1699.
41. Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. J Am Med Assoc 2000; 283(24): 3230-3235.
42. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990; 6(4): 703-719.
43. Eastman RC. Cost-effectiveness of treatment of type 2 diabetes. Diabetes Care 1998; 21(3): 464-465.
44. Huang ES, Jin L, Shook M, Chin MH, Meltzer DO. The impact of patient preferences on the costeffectiveness of intensive glucose control in older patients with new onset diabetes. Diabetes Care 2006; 29(2): 259-264.
45. Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years or older. J Am Med Assoc 1998; 279(5): 371-375.
46. Hardy SE, Gill TM. Recovery from disability among community-dwelling older persons. J Am Med Assoc 2004; 291(13): 1596-1602.